David Preiner

David Preiner is the Founder & CEO of Remitz, Inc., CEO of Medivolve, and Founder & CEO of Xenomics. David is also the Founder of Amino Therapeutics, Biotii Technologies, and Freedom Financial and Affiliates. Prior to their current roles, David worked as a Neurodiagnostics Tech at Boston Children's Hospital and as a Marketing Director at Source Lending. David has a diverse background in pharmaceuticals, technology, finance, and healthcare, with a strong track record of leadership and innovation in various industries.